Fluorescent immunolabeling of cancer cells by quantum dots and antibody scFv fragment

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Diagnostics

Background:

• Human epidermal growth factor receptor 2/neu (HER2/neu) is overexpressed on many cancer cells, making it a key diagnostic target.
• Semiconductor quantum dots (QDs) conjugated with targeting ligands are emerging as potent tools for cancer cell imaging.
• Antibody single-chain variable fragments (scFv) provide advantages over full-size antibodies for targeted delivery due to their small size and reduced immunogenicity.

Purpose of the Study:

• To develop and evaluate quantum dots functionalized with anti-HER2/neu 4D5 scFv antibody fragments for specific cancer cell labeling.
• To assess the efficacy of QD-scFv conjugates for fluorescent visualization of HER2/neu-overexpressing cells.

Main Methods:

• Conjugation of anti-HER2/neu 4D5 scFv antibody fragments to semiconductor quantum dots.
• Labeling of live cancer cells overexpressing HER2/neu with the developed QD-scFv constructs.
• Evaluation of labeling characteristics, including brightness, photostability, and specificity.

Main Results:

• Successful labeling of HER2/neu-overexpressing live cells was achieved using quantum dots linked to anti-HER2/neu 4D5 scFv antibody.
• The labeling demonstrated high brightness, excellent photostability, and specific targeting of cancer cells.
• The QD-scFv conjugates effectively visualized target cancer cells.

Conclusions:

• Quantum dot-scFv antibody conjugates are effective for specific and sensitive fluorescent visualization of cancer cells.
• This technology holds significant potential for improving cancer diagnostics and imaging applications.
• The combination of QDs and scFv antibodies presents a promising strategy for targeted cancer cell detection.